Stoke Therapeutics(STOK.US)董事售出4.24万股普通股股份,价值约65.35万美元

Stoke Therapeutics(STOK.US) Officer Sells US$653.53K in Common Stock

Futu News ·  May 23 05:01

$Stoke Therapeutics (STOK.US)$ Officer Kaye Edward M. MD sold 42,350 shares of common stock on May 20, 2024 at an average price of $15.4316 for a total value of $653.53K.


What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment